Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Quality of Life Research

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11136-006-9003-5PMID 17033909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

  2006cited by this paper
• Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.

  2005cited by this paper
• Chemotherapy-induced peripheral neuropathy.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model

  2004cited by this paper
• Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

  2004cited by this paper
• Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.

  2004cited by this paper
• Response of patients with panic disorder and symptoms of hypomania to cognitive behavior therapy for panic.

  2003cited by this paper
• Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.

  2003cited by this paper
• Interacting with cancer patients: the significance of physicians' communication behavior.

  2003cited by this paper
• Clinical Significance and Predictors of Treatment Response to Cognitive-Behavior Therapy for Insomnia Secondary to Chronic Pain

  2002cited by this paper
• Use of the Reliable Change Index to evaluate clinical significance in SF-36 outcomes

  2002cited by this paper
• Predictors of preferences, utilities and quality of life in men treated with 3DCRT for prostate cancer

  2002cited by this paper
• Methods to explain the clinical significance of health status measures.

  2002cited by this paper
• Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinic.

  2002cited by this paper
• Phase III evaluation of nortriptyline for alleviation of symptoms of cis‐platinum‐induced peripheral neuropathy

  2002cited by this paper
• Health-related Quality of Life of Patients with Endometrial Cancer Who are Disease-free Following External Irradiation

  2001cited by this paper
• Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy--evaluation of long-term effects of diagnosis and treatment.

  2000cited by this paper
• Psychosocial determinants of well-being in gynecologic cancer patients.

  1999cited by this paper
• Quality of life in endometrial cancer survivors.

  1999cited by this paper
• Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

  1998cited by this paper
• The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer.

  1998cited by this paper
• Impact of a Laryngectomy on Quality of Life: Perspective of the Patient versus That of the Health Care Provider

  1997cited by this paper
• Chemotherapy-induced peripheral neuropathy.

  1997cited by this paper
• Neuroprotectant drugs in cisplatin neurotoxicity.

  1996cited by this paper
• Assessing outcome in clinical practice

  1996cited by this paper
• Quality of life during pelvic radiotherapy

  1995cited by this paper
• The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

  1995cited by this paper
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

  1993cited by this paper
• Cisplatin‐lnduced peripheral neurotoxicity is dependent on total‐dose intensity and single‐dose intensity

  1992cited by this paper
• Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

  1991cited by this paper
• Sex or survival: trade-offs between quality and quantity of life.

  1991cited by this paper
• Clinical gynecologic oncology

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• High-dose cisplatin-related peripheral neuropathy.

  1988cited by this paper
• Symptom distress in patients receiving Phase I chemotherapy with taxol.

  1986cited by this paper
• Symptom distress in patients receiving Phase I chemotherapy with taxol.

  1986cited by this paper
• Patients' descriptions of the experience of receiving radiation therapy.

  1985cited by this paper
• Peripheral sensory neuropathy and cisplatin chemotherapy

  1984cited by this paper

• The GOG Foundation, Inc. Uterine Cancer Trials

  2023cites this paper
• Association Between Intermediate End Points, Progression-Free Survival, and Overall Survival in First-Line Advanced or Recurrent Endometrial Cancer.

  2023cites this paper
• Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study.

  2022cites this paper
• Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Review: Clinical Trials Outcome for Chemotherapy in Endometrial Cancer

  2020cites this paper
• Adjuvante Therapie des Endometriumkarzinoms

  2018cites this paper
• Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions

  2018cites this paper
• The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors

  2018cites this paper
• Lost Annual Productivity Costs Due to Uterine Cancer Deaths in the United States in 2014

  2018cites this paper
• がん化学療法による慢性末梢神経障害を 抱える患者のQ O L に及ぼす要因の分析

  2018cites this paper
• 20 – Palliative Care and Quality of Life

  2018cites this paper
• jakości życia dokonywana przez chore na raka endometrium Assessment of preoperative counselling and quality of life of patients with endometrial cancer

  2018cites this paper
• Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1

  2017cites this paper
• Ocena poradnictwa przedoperacyjnego i jakości życia dokonywana przez chore na raka endometrium

  2017cites this paper
• Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

  2017cites this paper
• [Postoperative radiation therapy for endometrial cancer : Rigorous and evidence-based processing of data still required].

  2016cites this paper
• Effect of Physical Activity on Quality of Life as Perceived by Endometrial Cancer Survivors: A Systematic Review

  2016cites this paper
• Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

  2016cites this paper
• Postoperative Radiotherapie des Endometriumkarzinoms

  2016cites this paper
• Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas.

  2016cites this paper
• Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

  2015cites this paper
• Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale.

  2015cites this paper
• Quality of Life and Patient-Reported Outcomes in Endometrial Cancer Clinical Trials: A Call for Action!

  2014cites this paper
• Nurse scientists in cancer cooperative groups.

  2014cites this paper
• The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view.

  2014cites this paper
• Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review

  2014cites this paper
• Quality of life (QOL) in women treated for gynecologic malignancies with radiation therapy: a literature review of patient-reported outcomes.

  2014cites this paper
• Quality of Life, Body Mass Index, and Physical Activity Among Uterine Cancer Patients

  2014cites this paper
• Nursing research in the Gynecologic Oncology Group.

  2014cites this paper
• Adjuvant chemotherapy for advanced endometrial cancer.

  2014cites this paper
• Conducting Nursing Intervention Research in a Cooperative Group Setting – A Gynecologic Oncology Group (GOG) Experience

  2014cites this paper
• Preference-Based Utility Scores for Adverse Events Associated With the Treatment of Gynecologic Cancers

  2013cites this paper
• Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO).

  2013cites this paper
• Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registry.

  2012cites this paper
• Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry

  2012cites this paper
• Palliative Care and Quality of Life

  2012cites this paper
• Cytotoxic Trials by the Gynecologic Oncology Group

  2011cites this paper
• Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress

  2011cites this paper
• Adjuvant chemotherapy for endometrial cancer after hysterectomy.

  2011cites this paper
• Expert panelDebate: Patients with endometrial carcinoma with extrauterine disease should receive chemotherapy after any indicated surgeryCON: Not All Patients With Endometrial Cancer With Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery

  2011cites this paper
• Current therapy of patients with endometrial carcinoma

  2011cites this paper
• Patient-Reported Outcomes in Chemotherapy-Induced Peripheral Neuropathy: A Review

  2010cites this paper
• Assessment and significance of quality of life in women with gynecologic cancer.

  2010cites this paper
• Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184.

  2010cites this paper
• Symptoms before, during, and 14 months after the beginning of treatment as perceived by patients with lymphoma.

  2010cites this paper
• Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.

  2010cites this paper
• Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma

  2010cites this paper
• Assessing Health-Related Quality of Life in Gynecologic Oncology: a Systematic Review of Questionnaires and Their Ability to Detect Clinically Important Differences and Change

  2009cites this paper
• Recent progress: gynecologic oncology group trials in uterine corpus tumors.

  2009cites this paper
• Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.

  2008cites this paper
• CON: Not All Patients With Endometrial Cancer With Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery

  2008cites this paper
• Gynecologic oncology group trials in uterine corpus malignancies: recent progress.

  2008cites this paper
• The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients

  2007cites this paper
• Adjuvante Therapie des Endometriumkarzinoms

  2006cites this paper
• Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up

  year unknowncites this paper